This is a large‐scale GWAS and MR study linking breast cancer to an increased risk of meningiomas and finding that breast cancer, especially HER‐2 positive breast cancer, raises the risk of meningiomas, which suggests genetic causation and has important clinical implications for the prevention and treatment of meningiomas. Here, ERBB2 is linked to meningioma.